Blastic plasmacytoid dendritic cell neoplasia (BPDCN) is an aggressive hematologic malignancy originating from immature plasmacytoid dendritic cell (PDC) precursors. The initial manifestation of BPDCN often consists of cutaneous lesions. In this educational article, the clinical, histologic and therapeutic aspects of BPDCN are discussed from a dermatologic perspective.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Helicobacter pylori infection
Simplified dual therapy beats quadruple regimen
- Gastric carcinoma
Ways of precision oncology
- Endometrial Cancer
Immunological drivers and new therapeutic pathways
- Exercise for type 1 diabetes
Cyclists and runners with an increased risk of hypoglycemia
- Ozanimod for relapsing-remitting multiple sclerosis
Signs of improved tolerability with prolonged treatment
- When basal cell carcinomas prove difficult to treat
Reaching the goal with innovative therapy strategies
- Irritable Bowel Syndrome
IBS or endometriosis?
- Type 2 diabetes: sarcopenia and frailty